Back to results
US 2013/0281407 A1Published application
Novel phosphonic acid compounds as inhibitors of serine proteases
AssigneeJanssen Pharmaceutica NV
InventorsMichael N. Greco, Harold R. Almond, Michael J. Hawkins, Eugene Powell
Life of this patent
Estimating the term…
Abstract
The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
Claims5
A compound that is [1-(5-chlorobenzo[b]thien-3-yl)-2-[3-[[methyl[1-(2-naphthalenylcarbonyl)-4-piperidinyl]amino]carbonyl]-2-naphthalenyl]-2-oxoethyl]-phosphonic acid,
- and racemates, enantiomers, diastereomers and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.